Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 2/2013

01-04-2013 | Case Report

Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient

Authors: P. Donati, G. Paolino, C. Panetta, L. Muscardin, C. Cota, M. Giuliani

Published in: Infection | Issue 2/2013

Login to get access

Abstract

We present a case of visceral leishmaniasis confirmed after the histological investigation of an ulcerate lesion of the scalp in an HIV-1-infected patient receiving highly active antiretroviral therapy (HAART). Histological examination of the skin lesion revealed a squamous cell carcinoma superinfected by amastigotes of Leishmania infantum from the bloodstream. Because HIV-1-infected individuals can harbour parasitic infections in normal and neoplastic tissue, it is necessary to examine carefully any skin lesions, particularly those with uncommon aspects or a worsening course, to exclude superinfections by unsuspected pathogens.
Literature
1.
Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97:3–15.PubMedCrossRef
2.
Paredes R, Munoz J, Diaz I, et al. Leishmaniasis in HIV infection. J Postgrad Med. 2003;49:39–49.PubMedCrossRef
3.
Gradoni L, Scalone A, Gramiccia M, Troiani M. Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS. 1996;10:785–91.PubMedCrossRef
4.
Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev. 2008;21:334–59.PubMedCrossRef
5.
Garg R, Barat C, Ouellet M, Lodge R, Tremblay MJ. Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4+ T cells by inducing secretion of IL-6 and TNF-α. PLOS Negl Trop Dis. 2009;3:e441.PubMedCrossRef
6.
Jimenez-Exposito MJ, Alonso-Villaverde C, Sarda P, Masana L. Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy. AIDS. 1999;13:152–3.PubMed
7.
Gallego MA, Aguillar A, Plaza S, et al. Kaposis’s sarcoma with an intense parasitization by Leishmania. Cutis. 1996;57:103–5.PubMed
8.
Castellano VM, Rodriguez-Peraltro JL, Alonso S, Gomez-De la Fuente E, Ibarrola C. Dermatofibroma parasitized by Leishmania in HIV infection: a new morphologic expression of the dermal Kala Azar in an immunodepressed patient. J Cutan Pathol. 1999;26:516–9.PubMedCrossRef
9.
Bosch RJ, Rodrigo AB, Sanchez P, de Galvez MV, Herrera E. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis. Int J Dermatol. 2002;41:670–5.PubMedCrossRef
10.
Perrin C, Michielis JF, Bernard E, et al. Cutaneous spindle-cell pseudotumors due to mycobacterium gordonae and Leishmania Infantum: an immunophenotypic study. Am J Dermatopathol. 1993;15:553–8.PubMedCrossRef
11.
Antinori S, Calattini S, Longhi E, et al. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Clin Infect Dis. 2007;44:1602–10.PubMedCrossRef
12.
Bourgeois N, Bastien P, Reynes J, Makinson A, Rouanet I, Lachaud L. ‘Active chronic visceral leishmaniasis’ in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients. HIV Med. 2010;11:670–3.PubMedCrossRef
13.
de Oliveira CP, Junger J, do Espirito Santo Silva Pires F, Mattos M, Oliveira-Neto MP, Fernandes O, Pirmez C. Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis. Trans R Soc Trop Med Hyg. 2006;100:1112–7.CrossRef
14.
del Giudice P, Marty P, Lacour JP, Perrin C, Pratlong F, Haas H, Dellamonica P, Le Fichoux Y. Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. Arch Dermatol. 1998;134(2):193–8.PubMedCrossRef
15.
Boutros N, Hawkins D, Nelson M, et al. Burkitt lymphoma and leishmaniasis in the same tissue sample in an AIDS patient. Histopathology. 2006;48:880–1.PubMedCrossRef
16.
Kopterides P, Mourtzoukou EG, Skopelitis E, et al. Aspects of the association between leishmaniasis and malignant disorders. Trans R Soc Trop Med Hyg. 2007;101:1181–9.PubMedCrossRef
17.
Friedman R, Hanson S, Goldberg LH, et al. Squamous cell carcinoma arising in a Leishmania scar. Dermatol Surg. 2003;29:1148–9.PubMedCrossRef
18.
Bielory BP, Lari HB, Mirani N, Kapila R, Fizhugh VA, Turbin RE. Conjunctival squamous cell carcinoma harbouring Leishmania amastigotes in a human immunodeficiency virus positive patient. Arch Ophtalmol. 2011;129:1230–1.CrossRef
19.
Armengot-Carbò M, Carmen-Ramon R, Nicolas-Rodrigo B, Marco-Ferrando J. Unsuspected visceral leishmaniasis infiltrating a squamous cell carcinoma. Actas Dermosifiliogr. 2012;103:321–323.
Metadata
Title
Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient
Authors
P. Donati
G. Paolino
C. Panetta
L. Muscardin
C. Cota
M. Giuliani
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Infection / Issue 2/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0412-4

Other articles of this Issue 2/2013

Infection 2/2013 Go to the issue

Clinical and Epidemiological Study

Risk factors for non-Escherichia coli community-acquired bacteriuria

Case Report

Meningitis caused by Abiotrophia defectiva: case report and literature review

Clinical and Epidemiological Study

Clinical and pathological characteristics of mycobacterial tenosynovitis and arthritis

Clinical and Epidemiological Study

Extrapulmonary mycobacterial infections in a cohort of HIV-positive patients: ultrasound experience from Vicenza, Italy

Clinical and Epidemiological Study

Absence of liver steatosis in HIV–HCV co-infected patients receiving regimens containing tenofovir or abacavir

Clinical and Epidemiological Study

All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART)

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits